Clinical Trials Sponsored by Asta Krikscionaitiene

Total 418 results

Lithuanian University of Health Sciences
Egle Vaitkaitiene; Dinas Vaitkaitis; Asta Krikscionaitiene; Ilona Kajokaite; Nerijus...

Completed

Out-of-hospital Cardiac Arrest Epidemiology and Outcomes in Kaunas 2016-2021

Out-Of-Hospital Cardiac Arrest

Lithuania
Aspa Therapeutics

Recruiting

Natural History Study of Patients With Canavan Disease

Canavan Disease

United States, Germany
Columbia Asia

Completed

Effect of Wearing of White Coat on Patient Satisfaction in Indian Out Patient Department (OPD) Setting

Patient Compliance | Physician-Patient Relations

India
Asia University

Not yet recruiting

Effectiveness of Recruitment Maneuvers and Lung Protective Ventilation Strategy in ARDS (ARDS)

ARDS

Taiwan
Aspa Therapeutics

Recruiting

A Study of AAV9 Gene Therapy in Participants With Canavan Disease (CANaspire)

Canavan Disease

United States
Asia University

Active, not recruiting

Effects of Acupressure at Sanyinjiao Point on Primary Dysmenorrhea Among University Students.

Primary Dysmenorrhea | Acupuncture

Taiwan
Asia University

Completed

A Caregiver-mediated Health Educational Intervention to Improve Constipation Status of Primary School Children

Constipation

Taiwan
Asia University

Active, not recruiting

Protein Supplementation Intervention for Improving Muscle Mass and Physical Performance in Older People With Sarcopenia

Sarcopenia

Taiwan
Asia University

Completed

A Need-based Nutritional Intervention in Nursing Home Residents

Malnutrition

Taiwan
Columbia Asia

Unknown

Hair Fall in Patients on Low Dose Methotrexate

Rheumatoid Arthritis | Alopecia | Methotrexate Adverse Reaction

India
ASQA a.s.

Unknown

Lithium Dilution Method in Guiding Fluid Therapy in Critically Ill Patients (LIGA)

Critical Illness

Czech Republic
Asia Diabetes Foundation

Completed

Effectiveness of a Treat-to-target Clinic Led by a Nurse Consultants

Diabetes

Hong Kong
Asia Diabetes Foundation

Completed

PLATINUM Program: A Feasibility Study on a Train-the-trainer Course on Peer Support for People With Type 2 Diabetes (PLATINUM)

Diabetes

Hong Kong
Asia Diabetes Foundation

Completed

Comparing the Effect of Structured Care Versus Usual Care in Type 2 Diabetes Patients Across the Asia Pacific Region (AP-JD)

Diabetes

Hong Kong
Asia Diabetes Foundation

Unknown

Evaluation of Morbidities, Endpoints and Reaching Targets in Diabetic Patients Managed by a Diabetes Specialist Team (EMERALD)

Obesity | Diabetes

Hong Kong
Asia Diabetes Foundation

Unknown

An Evaluation of the Effectiveness and Acceptability of Delivering Structured Care in Chinese Type 2 Diabetic Patients (JADE-JA)

Diabetes

China
Contact Asia Pacific

Unknown

Observation Only Study Involving Participants Enrolled in the CHAT Trial

Breast Cancer

Australia
Asia Diabetes Foundation

Completed

Using a Diabetic Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT) (DKD-TMT)

Diabetic Kidney Disease

Taiwan, China, Hong Kong, Korea, Republic of, Malaysia, Thailand, Vietnam
Asia Diabetes Foundation

Completed

Establishing a Diabetes Registry Using the JADE-DIAMOND Electronic Portal (CN001) (China-JD)

Diabetes

Hong Kong
Medistim ASA

Not yet recruiting

Peripheral Bypass Trial for Completion Control (PATENT)

Chronic Limb-Threatening Ischemia
BerGenBio ASA

Recruiting

A Study to Investigate the Safety, Tolerability, and Preliminary Anti-tumor Activity of Bemcentinib in Combination With Pembrolizumab Plus Pemetrexed and Carboplatin in Adult Participants With Untreated Non-squamous Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
BerGenBio ASA

Terminated

A Study of Tilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) Participants

Ovarian Neoplasms

Korea, Republic of, Singapore, United Kingdom, Norway
Ultimovacs ASA

Active, not recruiting

UV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma

Malignant Melanoma

United States
BerGenBio ASA

Completed

A Study of BGB324(Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Targovax ASA

Completed

Antigen-specific Cancer Immunotherapy (TG01) and Gemcitabine as Adjuvant Therapy in Resected Pancreatic Cancer

Pancreatic Cancer, Resected

Norway, Spain, United Kingdom
Medistim ASA

Completed

Registry for Quality Assessment With Ultrasound Imaging and TTFM in Cardiac Bypass Surgery (REQUEST)

Coronary Artery Bypass

United States, United Kingdom, Netherlands, Canada, Germany, Italy
Medistim ASA

Not yet recruiting

Collect Flow and Ultrasound Images of Coronary Bypass Grafts (CASES)

Cardiac Bypass Surgery (CABG)
Ultimovacs ASA

Completed

UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma

Malignant Melanoma

United States, Belgium, United Kingdom, Norway
Ultimovacs ASA

Active, not recruiting

TENDU Vaccine in Patients With Relapse After Primary Radical Prostatectomy

Prostate Cancer

Norway
Targovax ASA

Terminated

Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer

Rectal Cancer

New Zealand, Australia
BerGenBio ASA

Completed

A Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients

COVID-19

India, South Africa
Ultimovacs ASA

Active, not recruiting

A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancer (UV1/hTERT2012P)

Prostate Cancer

Norway
BerGenBio ASA

Completed

A First-time-in-human Study of BGB149

Healthy Volunteers

United Kingdom
BerGenBio ASA

Active, not recruiting

A Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS

Acute Myeloid Leukemia | Myelodysplastic Syndromes

United States, Germany, Italy, Norway
Wuhan Asia Heart Hospital

Not yet recruiting

Non-IRA Functional Evaluation With AccuFFRangio in NSTE-ACS

Coronary Artery Disease | Percutaneous Coronary Intervention | Non ST Segment Elevation Acute Coronary Syndrome
McGuire Institute
Asua, Inc

Active, not recruiting

Development of an AI App to Improve Compliance in Periodontal Maintenance Patients

Periodontal Diseases

United States
ASKA Pharmaceutical Co., Ltd.

Completed

Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With Endometriosis

Endometriosis

Japan
Wuhan Asia Heart Hospital

Completed

Social-software iMproving wARfarin Therapy (SMART)

Patient Compliance | Anticoagulants Causing Adverse Effects in Therapeutic Use

China
Wuhan Asia Heart Hospital

Unknown

Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia

Thrombosis | Biomarkers | Heparin-Induced Thrombocytopenia
Wuhan Asia Heart Hospital
Wuhan Asia General Hospital (http://wagh.com.cn)

Not yet recruiting

Laboratory Assessment of the Concentration of Direct Oral Anticoagulants in Patients With Atrial Fibrillation (LOAF)

Atrial Fibrillation | Oral Anticoagulant | Pharmacokinetics and Pharmacodynamics
Wuhan Asia Heart Hospital

Not yet recruiting

Prognostic Implications of AccuFFRangio-guided PCI in STEMI

Coronary Artery Disease | ST Elevation Myocardial Infarction
Wuhan Asia Heart Hospital

Not yet recruiting

Detection and Pathogenesis of Novel Protein F

Multiple Myeloma | Cardiac Disease
Wuhan Asia Heart Hospital

Recruiting

Central China Congenital Heart Disease Associated Pulmonary Arterial Hypertension Cohort Study (CHD-PAHCS)

Pulmonary Arterial Hypertension

China
Wuhan Asia Heart Hospital

Active, not recruiting

D-dimer to Improve Anticoagulation Outcome During ECMO loNg-term supporteD (DIAMOND)

Hemorrhage | Thrombosis | Extracorporeal Membrane Oxygenation Complication | Heparin Overdose

China
Wuhan Asia Heart Hospital

Unknown

Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy (REDUCE)

Valve Heart Disease | Anticoagulants; Increased

China
Wuhan Asia Heart Hospital

Unknown

Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring (CATCH)

Myocardial Infarction | Stroke | Bleeding | Venous Thromboembolism

China
Wuhan Asia Heart Hospital

Completed

The Roles of Intraluminal Pressure and the Dilation of Tunica Media in the Development of Aortic Dissection

Aortic Dissection

China
Wuhan Asia Heart Hospital

Recruiting

Multi-marker Approach for Risk Assessment in PAH (MARS)

Pulmonary Arterial Hypertension

China
United Biomedical Inc., Asia

Withdrawn

A Study to Evaluate the Ability of UB-612 COVID-19 Vaccine to Boost Immunity of Heterologous COVID-19 Vaccines.

COVID-19
Wuhan Asia Heart Hospital

Completed

Evaluation of Soluble ST2 in Patients Receiving Primary PCI With ST-elevation Myocardial Infarction

Myocardial Infarction | Shock

China

3

Subscribe